Please assess the completion status of the following clinical trial:

Trial Title: Repeated TMS at Low Frequencies to Reduce Seizure Occurrence

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Long-term protocol:~Inclusion Criteria:~* Experience ≥ 3 seizures/month in the month prior to starting study (any type of seizure will count)~* No status epilepticus in the last 12 months~* No change in medication in last 30 days~Exclusion Criteria:~* Presence of implanted electronic devices (e.g., pacemaker, medication pump, brain or vagus nerve stimulator, cochlear implant)~* Presence of intracranial metal (e.g., aneurysm clip)~* Unable to cooperate with non-sedated, navigated TMS testing~Short-term protocol:~Inclusion Criteria:~* Epilepsia partialis continua or status epilepticus~* At least 2 medications failed~* At least 24 hours of acute phase~Exclusion Criteria:~* Presence of implanted electronic devices (e.g., pacemaker, medication pump, brain or vagus nerve stimulator, cochlear implant)~* Presence of intracranial metal (e.g., aneurysm clip)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Group 1: Weekly TMS (Type: EXPERIMENTAL): LF-rTMS intervention for 2 weeks (5 days per week for total of 10 days) , LF-rTMS 1 session/week for 1 month (4 days), and LF-rTMS 1 session/month for 11 months
- Group 2: Monthly TMS (Type: EXPERIMENTAL): LF-rTMS intervention for 2 weeks (5 days per week for total of 10 days), LF-rTMS 1 session/month for 12 months
- Group 3: Sham TMS (Type: SHAM_COMPARATOR): Sham LF-rTMS for 2 weeks (5 days per week for a total of 10 days), sham LF-rTMS 1 session/week for 1 month (4 days), and sham LF-rTMS 1 session/month for 1 month. After the sham stimulation real LF-rTMS intervention sessions will be delivered as follows: 50% of placebo group will follow group 1 protocol and the other 50% will follow group 2 protocol
- Short-term protocol (Type: EXPERIMENTAL): LF-rTMS intervention daily for up to 5 days in medically refractory status epilepticus participants only

Based on this trial design, predict the completion outcome and termination type (if applicable).